The effect of nicotinic acid and pentylenetetrazol in the therapy of psychiatric symptoms of cerebral arteriosclerosis.
D001161:Arteriosclerosis; D006801:Humans; D002537:Intracranial Arteriosclerosis; D001523:Mental Disorders / Q000209:etiology*; D009525:Niacin / Q000627:therapeutic use*; D009539:Nicotinic Acids; D009657:North Carolina; D010433:Pentylenetetrazole / Q000627:therapeutic use*
D009539:Nicotinic Acids; D009525:Niacin; D010433:Pentylenetetrazole
ARTERIOSCLEROSIS; MENTAL DISORDERS/etiology and pathogenesis; NICOTINIC ACID/therapeutic use; PENTYLENETETRAZOLE/therapeutic use